Federal regulators say shortages of Ozempic and Wegovy have been resolved, as supplies of popular diabetes and obesity ...

Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic are no longer in shortage, the US Food and Drug Administration said on Friday.

Following the resolution of Eli Lilly’s tirzepatide shortage in October, the FDA has officially declared an end to the supply ...

Entering Prime IV Hydration & Wellness in Orem is like entering a spa, rather than a physician’s office, with the lights ...

Two Omaha women lost more than 300 lbs. combined with injections of a GLP-1 drug, which are used increasingly for weight loss ...

Dec. 11, 2024 — Many vitamins are produced in chemical factories, often synthetically, but researchers have succeeded in developing a natural and simple method for producing vitamin B2 ...

Not all weight loss programs are made equal—to reach a healthy, sustainable weight, personalized programs offer the best ...

PATIENTS taking blockbuster diabetes and weight loss drugs are waking up with vision loss, researchers warn. Some reported ...

Detailed price information for Hims & Hers Health Inc (HIMS-N) from The Globe and Mail including charting and trades.

Experts warn Ozempic and Mounjaro may cause sudden, irreversible blindness as patients report vision loss after taking the ...

A new review reports that nine people taking semaglutide and tirzepatide — the active ingredient in GLP-1 medications — ...

WEIGHT-loss jabs are taking the world by storm, with a staggering half a million of us now using them. The injections have ...